Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Pain (London, England)
|
October 15, 2016
Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
O M S Fredheim, S Brelin, M J Hjermstad, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
H S Haugnes, N Aass, S D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
N Aass, O Klepp, E Cavallin-Stahl, et al.
British Journal of Cancer
|
July 2, 1999
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
K D Jacobsen, S Ous, H Waehre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
J A Christian, R A Huddart, A Norman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancer
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
December 1, 1994
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
S D Fosså, A B Jacobsen, N Aass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
S D Fosså, N Aass, A Heilo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group
O Klepp, A M Olsson, H Henrikson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
G Daugaard, I Skoneczna, N Aass, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Pain (London, England)
|
October 15, 2016
Prescriptions of analgesics during complete disease trajectories in patients who are diagnosed with and die from cancer within the five-year period 2005-2009
O M S Fredheim, S Brelin, M J Hjermstad, et al.
Journal of Cancer Survivorship : Research and Practice
|
September 17, 2008
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
H S Haugnes, N Aass, S D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
N Aass, O Klepp, E Cavallin-Stahl, et al.
British Journal of Cancer
|
July 2, 1999
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
K D Jacobsen, S Ous, H Waehre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
J A Christian, R A Huddart, A Norman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancer
H S Haugnes, N Aass, S D Fosså, et al.
British Journal of Cancer
|
December 1, 1994
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
S D Fosså, A B Jacobsen, N Aass, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 5, 2003
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
S D Fosså, N Aass, A Heilo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group
O Klepp, A M Olsson, H Henrikson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)
G Daugaard, I Skoneczna, N Aass, et al.
Page
of 7